Hematologie, ISSN 1264-7527, 09/2013, Volume 19, Issue 5, pp. 319 - 330
Journal Article
Hematologie, ISSN 1264-7527, 07/2008, Volume 14, Issue 3, pp. 14 - 20
Journal Article
Blood, ISSN 0006-4971, 10/2014, Volume 124, Issue 18, pp. 2758 - 2760
In this issue of Blood, Scheinberg et al investigate moderate-dose cyclophosphamide (120 mg/kg) in treatment-naive patients with severe aplastic anemia (SAA)....
HIGH-DOSE CYCLOPHOSPHAMIDE | HEMATOLOGY | Cyclophosphamide - adverse effects | Humans | Cyclophosphamide - therapeutic use | Anemia, Aplastic - drug therapy
HIGH-DOSE CYCLOPHOSPHAMIDE | HEMATOLOGY | Cyclophosphamide - adverse effects | Humans | Cyclophosphamide - therapeutic use | Anemia, Aplastic - drug therapy
Journal Article
Bulletin du Cancer, ISSN 0007-4551, 08/2011, Volume 98, Issue 8, pp. 889 - 899
Journal Article
Medicine (United States), ISSN 0025-7974, 2017, Volume 96, Issue 12, p. e6403
Paroxysmal nocturnal hemoglobinuria (PNH) is a nonmalignant acquired hematopoietic stem cell disease, which can be revealed by hemolytic anemia,...
Eculizumab | Coronary thrombosis | PNH | Coronary Vessels - diagnostic imaging | Coronary Thrombosis - diagnosis | Antibodies, Monoclonal, Humanized - therapeutic use | Hemoglobinuria, Paroxysmal - physiopathology | Humans | Male | Coronary Thrombosis - drug therapy | Delayed Diagnosis | Coronary Thrombosis - physiopathology | Fatal Outcome | Hemoglobinuria, Paroxysmal - drug therapy | Aged | Hemoglobinuria, Paroxysmal - diagnosis | Immunologic Factors - therapeutic use | Blood diseases | Drug therapy
Eculizumab | Coronary thrombosis | PNH | Coronary Vessels - diagnostic imaging | Coronary Thrombosis - diagnosis | Antibodies, Monoclonal, Humanized - therapeutic use | Hemoglobinuria, Paroxysmal - physiopathology | Humans | Male | Coronary Thrombosis - drug therapy | Delayed Diagnosis | Coronary Thrombosis - physiopathology | Fatal Outcome | Hemoglobinuria, Paroxysmal - drug therapy | Aged | Hemoglobinuria, Paroxysmal - diagnosis | Immunologic Factors - therapeutic use | Blood diseases | Drug therapy
Journal Article
Blood, ISSN 0006-4971, 12/2019
Journal Article
Medecine/Sciences, ISSN 0767-0974, 12/2009, Volume 25, Issue 12, pp. 1126 - 1129
Journal Article
Medicine (United States), ISSN 0025-7974, 01/2015, Volume 94, Issue 1, p. e362
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired disorder of hematopoietic stem cells characterized by hemolytic anemia, marrow failure, and a high...
ECULIZUMAB | MEDICINE, GENERAL & INTERNAL | MARCHIAFAVA-MICHELI-SYNDROME | PROGNOSTIC-FACTORS | DURAL SINUS THROMBOSIS | DISEASE | FOLLOW-UP | HEPARIN-INDUCED THROMBOCYTOPENIA | PATIENT | NATURAL-HISTORY | PREGNANCY | Young Adult | Intracranial Thrombosis - etiology | Humans | Adolescent | Adult | Female | Male | Retrospective Studies | Hemoglobinuria, Paroxysmal - complications | Case studies | Complications and side effects | Care and treatment | Venous thrombosis | Research | Hemoglobinuria, Paroxysmal | Risk factors
ECULIZUMAB | MEDICINE, GENERAL & INTERNAL | MARCHIAFAVA-MICHELI-SYNDROME | PROGNOSTIC-FACTORS | DURAL SINUS THROMBOSIS | DISEASE | FOLLOW-UP | HEPARIN-INDUCED THROMBOCYTOPENIA | PATIENT | NATURAL-HISTORY | PREGNANCY | Young Adult | Intracranial Thrombosis - etiology | Humans | Adolescent | Adult | Female | Male | Retrospective Studies | Hemoglobinuria, Paroxysmal - complications | Case studies | Complications and side effects | Care and treatment | Venous thrombosis | Research | Hemoglobinuria, Paroxysmal | Risk factors
Journal Article
Bulletin du Cancer, ISSN 0007-4551, 01/2008, Volume 95, Issue 1, pp. 87 - 97
Journal Article
Bulletin du Cancer, ISSN 0007-4551, 01/2007, Volume 94, Issue 1, pp. 33 - 41
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 4802 - 4802
INTRODUCTION Paroxysmal nocturnal hemoglobinuria (PNH) patients treated with eculizumab have an increased susceptibility to serious meningococcal infections....
Journal Article
Haematologica, ISSN 0390-6078, 11/2019, p. haematol.2019.226134
Journal Article
13.
Full Text
281 - Cryostem: A French National Biobank to Move Research Forward in the Field of GvHD
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 03/2018, Volume 24, Issue 3, pp. S209 - S209
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 03/2018, Volume 24, Issue 3, p. S209
Journal Article
Revue du Praticien, ISSN 0035-2640, 04/2007, Volume 57, Issue 7, pp. 701 - 703
Journal Article
Revue du Praticien, ISSN 0035-2640, 12/2008, Volume 58, Issue 19, pp. 2123 - 2128
Journal Article
Experimental Hematology, ISSN 0301-472X, 2016, Volume 44, Issue 9, pp. 811 - 816.e3
Lymphoid-committed CD34+ lin− CD10+ CD24− progenitors undergo a rebound at month 3 after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in the...
Hematology, Oncology and Palliative Medicine | Advanced Basic Science | MEDICINE, RESEARCH & EXPERIMENTAL | HEMATOLOGY | Lymphoid Progenitor Cells - metabolism | Humans | Middle Aged | Immunophenotyping | Male | Transplantation, Homologous | Young Adult | Phenotype | Energy Metabolism | Hematopoietic Stem Cell Transplantation - adverse effects | Biomarkers | Adult | Female | Graft vs Host Disease - diagnosis | Graft vs Host Disease - etiology | Physiological aspects | Protein biosynthesis | Transplantation | Analysis | Hematopoietic stem cells | Stem cells
Hematology, Oncology and Palliative Medicine | Advanced Basic Science | MEDICINE, RESEARCH & EXPERIMENTAL | HEMATOLOGY | Lymphoid Progenitor Cells - metabolism | Humans | Middle Aged | Immunophenotyping | Male | Transplantation, Homologous | Young Adult | Phenotype | Energy Metabolism | Hematopoietic Stem Cell Transplantation - adverse effects | Biomarkers | Adult | Female | Graft vs Host Disease - diagnosis | Graft vs Host Disease - etiology | Physiological aspects | Protein biosynthesis | Transplantation | Analysis | Hematopoietic stem cells | Stem cells
Journal Article
18.
Graft failure after allogeneic hematopoietic stem cell transplantation: Definition and risk factors
Bulletin du Cancer, ISSN 0007-4551, 06/2019, Volume 106, Issue 6, pp. 574 - 583
Allogeneic hematopoietic stem cell transplantation is the only curative therapy for numerous malignant and non-malignant haematological diseases. A sustained...
Rejection | Allogeneic hematopoietic stem cell transplantation | Infections | Graft failure
Rejection | Allogeneic hematopoietic stem cell transplantation | Infections | Graft failure
Journal Article
19.
Full Text
Late Donor Bone Marrow Failure After Allogeneic Hematopoietic Stem Cell Transplantation
Transplantation, ISSN 0041-1337, 06/2014, Volume 97, Issue 12, pp. e75 - e77
SURGERY | VIRUS | INFECTION | LEUKEMIA | ANEMIA | IMMUNOLOGY | TRANSPLANTATION | Reoperation | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Pancytopenia - diagnosis | Male | Pancytopenia - etiology | Living Donors | Adrenal Cortex Hormones - therapeutic use | Anemia, Aplastic - blood | Pancytopenia - therapy | Transplantation Chimera | Anemia, Aplastic - therapy | Transplantation, Homologous | Anemia, Aplastic - diagnosis | Anemia, Aplastic - etiology | Time Factors | Treatment Failure | Adolescent | Hematopoietic Stem Cell Transplantation - adverse effects | Female | Pancytopenia - blood | Child
Journal Article
Hematologie, ISSN 1264-7527, 11/2010, Volume 16, Issue 6, pp. 420 - 429
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.